Sanuwave Health, Inc. SNWV
NASDAQ · United States · Health Technology
$4.82+0.20 (+4.33%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Despite a 13% surge in recurring applicator revenue, the company faces headwinds from a 34% drop in system sales and proposed CMS reimbursement cuts, leading to a withdrawal of FY2026 guidance.
Moby summary of SANUWAVE Health, Inc.'s Q2 2026 earnings call
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.